Mwandishi:
Mhariri:
Imeboreshwa:
6 Juni 2026, 03:53:32
Management of Critical COVID-19 Disease
Management of Critical COVID-19 Disease
CRITICAL COVID-19 DISEASE
Includes:
Respiratory failure
Septic shock
Multi-organ dysfunction
May progress toSeptic shock
ICU ADMISSION REQUIRED
i. Airway & Ventilation
Intubate if airway not protected
Mechanical ventilation:
SpO₂ target > 90%
Tidal volume 4–8 mL/kg
Plateau pressure < 30 cmH₂O
ii. Oxygenation
High-flow oxygen → NIV → Mechanical ventilation
Awake or ventilated proning
iii. Steroids
Same as severe disease
iv. Anticoagulation
Same protocol as severe disease
v. Hemodynamic support
IV fluids for shock
Maintain MAP ≥ 65 mmHg
Vasopressors if needed
vi. Antibiotics
Broad spectrum therapy then culture-guided
vii. Organ support
Renal support (dialysis if needed)
Nutrition therapy
Stress ulcer prophylaxis
Physiotherapy
Investigational/Adjunct therapies
Used in some settings:
Remdesivir
Tocilizumab
Colchicine
(Used selectively depending on protocol and availability)
CORE PRINCIPLE OF COVID-19 MANAGEMENT
Mild → symptomatic care
Moderate → anti-inflammatory therapy
Severe → oxygen + steroids + anticoagulation
Critical → organ support + ICU care
Imeandikwa:
26 Mei 2026, 07:49:45
